A major backlog has developed in handling complaints over drug companies’ marketing practices in the UK. Hristio Boytchev , Shai Mulinari , and Piotr Ozieranski report Processing times for complaints against drug companies suspected of having breached the UK industry’s code of practice governing the promotion of pharmaceuticals have more than tripled in nearly two decades, an investigation by The BMJ has found. Delays mean that any problematic practices highlighted in complaints can continue for an average of eight months—and in many cases for more than a year. To tackle the backlog, the...